IL17A and inflammatory bowel disease: Pathogenicity may reflect the modest switch to expression of the pathogenic cytokines IFNγ, IL-17A, and F (Figure 6B), although in other models of inflammatory bowel disease (IBD), the percentage of IFNγ producers can be much higher (41).